Novo Nordisk Aktie
50,79
EUR
+0,51
EUR
+1,01
%
46,29
CHF
+2,78
CHF
+6,39
%
Werbung
Novo Nordisk Aktie Analyse
31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
26.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
06.01.22 | Novo Nordisk Hold | Deutsche Bank AG | |
06.01.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
Werbung
|
|||
04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
21.12.21 | Novo Nordisk Hold | Kepler Cheuvreux | |
21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
20.12.21 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
07.12.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
26.11.21 | Novo Nordisk Neutral | UBS AG | |
26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
19.11.21 | Novo Nordisk Neutral | UBS AG | |
18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novo Nordisk Neutral | Credit Suisse Group | |
04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
03.11.21 | Novo Nordisk Neutral | UBS AG | |
03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.10.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
27.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
14.09.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
02.09.21 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
26.08.21 | Novo Nordisk Neutral | UBS AG | |
23.08.21 | Novo Nordisk Neutral | Credit Suisse Group | |
20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
17.08.21 | Novo Nordisk Neutral | UBS AG | |
17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
06.08.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung